Evidence map›Paper›PMID 21478254›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2011

Photolysis of caged sphingosine-1-phosphate induces barrier enhancement and intracellular activation of lung endothelial cell signaling pathways.

Peter V Usatyuk, Donghong He, Vytas Bindokas, Irina A Gorshkova, Evgeny V Berdyshev, Joe G N Garcia, Viswanathan Natarajan

2 registry-linked trialsAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03473119 unknown statusnot on this mapstarted 2016, after this paper: background citation

Acute Effects of Particulate Matter on Pulmonary Diseases: Discovery Its Chemo-signatures

TypeobservationalSponsorTaipei Medical University WanFang HospitalRan2016 to 2021Enrolled600ConditionsPneumonia, Chronic Obstructive Pulmonary Disease, Asthma
NCT04007328 phase2 / phase3unknown statusnot on this mapstarted 2019, after this paper: background citation

To Assess the Role of Sphingosine-1-phosphate in the Pathobiology of Pneumonia: Generate a New Strategy for Treatment of Severe Community-acquired Pneumonia

TypeinterventionalSponsorTaipei Medical University WanFang HospitalRan2019 to 2025Enrolled400ConditionsPneumonia, BacterialArmsMethylprednisolone Sodium Succinate, Placebo
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Pulmonary Vascular Dysfunctions in Cystic Fibrosis.Physiology (Bethesda, Md.) · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Lysophospholipids in Lung Inflammatory Diseases.Advances in experimental medicine and biology · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Cortical Actin Dynamics in Endothelial Permeability.Current topics in membranes · 2018
    Article
  16. In Development-A New Paradigm for Understanding Vascular Disease.Journal of cardiovascular pharmacology · 2017
    Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Peter V UsatyukDepartment of Pharmacology, University of Illinois at Chicago, 60612, USA.
Donghong He
Vytas Bindokas
Irina A Gorshkova
Evgeny V Berdyshev
Joe G N Garcia
Viswanathan Natarajan
University of Illinois Chicago · USUniversity of Chicago · US

Funding

Tissue Culture Biomechanical CoreP01HL058064 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAL, RATNESHWAR · 1998 to 2012
$27.8M
Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
Protective Role of Intracellular S1P in Lung InjuryR37HL079396 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2010 to 2010
$393k
NHLBI NIH HHS P01 HL058064NHLBI NIH HHS P01 HL 098050NHLBI NIH HHS P01 HL098050NHLBI NIH HHS R37 HL 079396
6 · The paper itself

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid that mediates cellular functions by ligation via G protein-coupled S1P receptors. In addition to its extracellular action, S1P also has intracellular effects; however, the signaling pathways modulated by intracellular S1P remain poorly defined. We have previously demonstrated a novel pathway of intracellular S1P generation in human lung endothelial cells (ECs). In the present study, we examined the role of intracellular S1P generated by photolysis of caged S1P on EC barrier regulation and signal transduction. Intracellular S1P released from caged S1P caused mobilization of intracellular calcium, induced activation of MAPKs, redistributed cortactin, vascular endothelial cadherin, and β-catenin to cell periphery, and tightened endothelial barrier in human pulmonary artery ECs. Treatment of cells with pertussis toxin (PTx) had no effect on caged S1P-mediated effects on Ca(2+) mobilization, reorganization of cytoskeleton, cell adherens junction proteins, and barrier enhancement; however, extracellular S1P effects were significantly attenuated by PTx. Additionally, intracellular S1P also activated small GTPase Rac1 and its effector Ras GTPase-activating-like protein IQGAP1, suggesting involvement of these proteins in the S1P-mediated changes in cell-to-cell adhesion contacts. Downregulation of sphingosine kinase 1 (SphK1), but not SphK2, with siRNA or inhibition of SphK activity with an inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (CII) attenuated exogenously administrated S1P-induced EC permeability. Furthermore, S1P1 receptor inhibitor SB649164 abolished exogenous S1P-induced transendothelial resistance changes but had no effect on intracellular S1P generated by photolysis of caged S1P. These results provide evidence that intracellular S1P modulates signal transduction in lung ECs via signaling pathway(s) independent of S1P receptors.

Indexed as

Adherens Junctionsbeta CateninBlotting, WesternCadherinsCalciumCells, CulturedCortactinCytoplasmCytoskeletonEndothelium, VascularFluorescent Antibody TechniqueHumansLungMitogen-Activated Protein KinasesOrganophosphatesPertussis Toxinbeta CateninCadherinscaged sphingosine 1-phosphateCalciumCortactinCTTN protein, humanIQ motif containing GTPase activating protein 1Mitogen-Activated Protein KinasesOrganophosphatesPertussis ToxinPhosphotransferases (Alcohol Group Acceptor)rac1 GTP-Binding Proteinras GTPase-Activating ProteinsReceptors, LysosphingolipidRNA, MessengerRNA, Small InterferingSphingosineSphingosine Kinase

Identifiers

PMID21478254
PMCPMC3119122
OpenAlexW2058955626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.